In vitro biosynthesis of complement factor I by human endothelial cells
✍ Scribed by Nathalie Julen; HÉLÈNe Dauchel; Claudie Lemercier; Robert B. Sim; Marc Fontaine; Jean Ripoche
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 513 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Antiangiogenic therapy for prostatic cancer should offer additional ways of combating tumor progression. knowledge of the possible angiogenic factors expressed by prostate cancer cell lines would therefore assist in the design and testing of such potential treatments. ## Methods: C
Bovine fetal aortic endothelial cells cultured in serum-containing medium accumulate angiotensin I-converting enzyme (ACE) activity and also release it into t h e culture medium. Following subcultivation of a confluent culture using trypsin-EDTA, cellular ACE activity falls 50% within 8 h, but n o A
## BACKGROUND. Interactions of cancer cells with endothelium are a crucial step in metastatic invasion. RGD-recognizing integrins play a definitive role in these interactions. METHODS. Fluorescence-activated cell sorting (FACS) analysis of RGD-sensitive integrins in prostate epithelial cells was pe